Histogen (FRA:CPH) Short-Term Capital Lease Obligation : €0.00 Mil (As of Sep. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Histogen Short-Term Capital Lease Obligation?

Histogen's Short-Term Capital Lease Obligation for the quarter that ended in Sep. 2023 was €0.00 Mil.

Histogen's quarterly Short-Term Capital Lease Obligation increased from Mar. 2023 (€0.24 Mil) to Jun. 2023 (€0.25 Mil) but then declined from Jun. 2023 (€0.25 Mil) to Sep. 2023 (€0.00 Mil).

Histogen's annual Short-Term Capital Lease Obligation increased from Dec. 2020 (€0.03 Mil) to Dec. 2021 (€0.12 Mil) and increased from Dec. 2021 (€0.12 Mil) to Dec. 2022 (€0.23 Mil).

Histogen Short-Term Capital Lease Obligation Historical Data

The historical data trend for Histogen's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Histogen Short-Term Capital Lease Obligation Chart

Histogen Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Short-Term Capital Lease Obligation

0.10

0.03

0.12

0.23

Histogen Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial													0.24	0.23	0.24	0.25	-

Histogen Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Histogen Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Histogen's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Histogen (FRA:CPH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Histogen Inc (FRA:CPH) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

HSTO:USA

Address

10655 Sorrento Valley Road, Suite 200, San Diego, CA, USA, 92121

Website

https://www.histogen.com

Histogen Inc is a clinical-stage therapeutics company focused on developing proprietary hypoxia-generated growth factor technology platforms and stem cell-free biologic products as potential first-in-class restorative therapeutics that ignite the body's natural process to repair and maintain healthy biological function. Under its biologics technology platform, the product candidates in development are HST-003, a treatment for joint cartilage repair, and HST-004, a treatment for spinal disc repair. It also has a pipeline of clinical and preclinical small molecule pan-caspase and caspase selective inhibitors focused on treatments for infectious and inflammatory diseases that the company intends to develop.

Histogen (FRA:CPH) Headlines

No Headlines